Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Satisfaction With Provider Services Edges Up, as Companies Seek More Innovation, ISG Study Shows
-
Walker & Dunlop Sources $110 Million for Refinance of NYC Multifamily Portfolio
-
OMNIVISION Announces Patent Litigation Victory Against VisionX Technologies, LLC
-
Boomer Benefits Unveils Insightful Article on Medicare Part D Payment Plan for 2025
-
METAGENOMI (NASDAQ: MGX) INVESTOR ALERT: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action
-
Rigel Announces Six Poster Presentations at the 66th American Society of Hematology Annual Meeting and Exposition
-
Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024
-
Umoja Biopharma Announces Oral and Poster Presentations at the 66th American Society of Hematology Annual Meeting
-
BeiGene Highlights Innovative Hematology Portfolio Across B-cell Malignancies at ASH 2024
-
bluebird bio to Present Additional Long-Term Follow-up Data from Gene Therapy Programs in Sickle Cell Disease and Beta-Thalassemia at the 66th American Society of Hematology (ASH) Annual Meeting and E
-
Agios to Present New Data on Mitapivat and Tebapivat in Rare Blood Disorders at 66th ASH Annual Meeting and Exposition
-
Alchemi's ShieldCRS Insider Threat Protection Platform Honored with Industry Accolades for Startup Achievement
-
Be Biopharma Announces Upcoming Presentation at the 66th American Society of Hematology (ASH) Annual Meeting
-
Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates
-
Lilly announces details of presentations at the 2024 American Society of Hematology (ASH) Annual Meeting
-
MedAllies Earns 2024 Great Place To Work Certification™
-
Envisio Names Craig Ross as CEO
-
Carahsoft to Host Webinar on Ensuring ICAM Survivability for Access in Disconnected, Degraded, Intermittent, and Low-Bandwidth (DDIL) Environments
-
Vheda Health Awarded Centene's Partnership Purpose Award
-
Announcing the Launch of Hypesquad.ai: AI-Powered Engagement, Comment Management, and Monetisation Tools
-
AMC Health Receives Expanded FDA Clearance for Advanced Virtual Care and Risk Prediction Technology
-
Could use a vacation right now: Elsa Pataky and Chris Hemsworth Partner with Experience Abu Dhabi
-
Mitchell and Protech Join Forces to Streamline Calibration Detection
-
Pompeian Sustainably Grown Certified Olive Oil
-
CXApp Inc. (Nasdaq: CXAI) Schedules Third Quarter 2024 Financial Results and Business Update Conference Call
-
Great Atlantic to Attend Newfoundland and Labrador Mineral Resources Review 2024 Conference
-
Petro Cohen Announces New Trustees to Atlantic County Bar Foundation
-
Epomaker Announces Grand 11.11 Shopping Fiesta for Cherished Supporters
-
Evexi Launches Self Ordering Kiosk App in Square App Marketplace to Provide an All-in-One Solution for in Store Digital Menu Boards and Integrated Self-Service Kiosks
-
NextTrip Plans to Acquire Luxury Travel Company Five Star Alliance
-
Honouring Veterans Through Second Careers During Veterans' Week
-
SAGA Metals Corp. Completes Second & Final Tranche of IPO Prospectus Offering
-
The Mortgage Calculator Launches FHA Mortgage Calculator with Live Mortgage Rates to Simplify the Home Buying Process
-
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results
-
Syndax to Host ASH Investor Event in Person and via Webcast on December 9, 2024
-
Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Ann
-
Nouscom’s Off-the-Shelf Neoantigen Immunotherapy, NOUS-209, Continues to Elicit Potent and Durable Immune Responses in Lynch Syndrome Carriers Highlighting its Potential to ‘Intercept’ Cancer
-
Rexas Finance (RXS) Closes Stage 4 of Its Presale Faster Than Projected, $5,450,000 Now Raised
-
Candel Therapeutics to Present Preclinical Data at SITC Annual Meeting Showing Promise for CAN-3110 in Melanoma, Signaling Potential Indication Expansion Beyond Recurrent High-Grade Glioma
-
Revolution Medicines to Participate in Upcoming Investor Conferences
-
Innovative Food Holdings, Inc. Announces Q3 2024 Earnings Call
-
UFP Technologies Announces Record Q3 2024 Results
-
Free Gold IRA Kit Now Available For Download
-
Nomad The Label US Announces Launch of Luxurious Linen Clothing Collection
-
MKS Instruments Declares Quarterly Cash Dividend
-
Cogent Biosciences Announces Bezuclastinib Presentations at the 66th Annual American Society of Hematology (ASH) Meeting
-
Tessera Therapeutics to Present New Preclinical Data From In Vivo Programs for Sickle Cell Disease and T-Cell Therapies at the 66th American Society of Hematology Annual Meeting
-
Nurix Therapeutics Announces Presentations at the 66th American Society of Hematology (ASH) Annual Meeting
-
Capricor Therapeutics to Present Third Quarter 2024 Financial Results and Recent Corporate Update on November 13
-
Syndax Announces Revumenib Abstracts to Be Presented at the 66th ASH Annual Meeting
